MedPath

Effect of Alprazolam on the Success of Inferior Alveolar Nerve (IAN) Block

Phase 3
Conditions
irreversible pulpitis.
Toothache NOS
Registration Number
IRCT201203032541N3
Lead Sponsor
Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

patients with active pain in a mandibular molar; prolonged response to cold testing; Absence of any periapical radiolucency on radiographs; a vital pulp while access cavity preparation; ability to understand the use of pain scales. Exclusion criteria: patients were having allergy, sensitivity, to benzodiazepines; pregnant and breast feeding patients; patients who had taken sedation within 24 hours before the treatment - having pain in more than one mandibular tooth - unable to give informed consent.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The success rate of the IAN block. Timepoint: 1 hour after alprazolam administration. Method of measurement: Heft-Parker visual analogue scale (pain scale).
Secondary Outcome Measures
NameTimeMethod
Anxity. Timepoint: before treatment initiation. Method of measurement: Corah dental anxity scale.;Initial pain. Timepoint: before alprazolam administration. Method of measurement: Heft-Parker visual analogue scale (a pain scale).
© Copyright 2025. All Rights Reserved by MedPath